Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Hosted content
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Hosted content
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 76, Issue Suppl 1
P99 The value of oral prednisolone in patients with severe eosinophilic asthma on mepolizumab treatment
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Emerging evidence on the use of biological agents in severe asthma
P99 The value of oral prednisolone in patients with severe eosinophilic asthma on mepolizumab treatment
Online download statistics by month:
Online download statistics by month: January 2021 to April 2022
Abstract
Full
Pdf
Jan 2021
45
0
1
Feb 2021
42
0
3
Mar 2021
34
0
1
Apr 2021
66
0
2
May 2021
19
0
1
Jun 2021
1
0
0
Jul 2021
0
0
1
Sep 2021
0
0
2
Oct 2021
42
0
0
Nov 2021
48
0
2
Dec 2021
14
0
0
Jan 2022
42
0
1
Feb 2022
44
0
3
Mar 2022
22
0
1
Apr 2022
34
0
0
Total
453
0
18
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF